Trends in Antiarrhythmic Drug Use Among Patients in the United States Between 2004 and 2016

Timothy M Markman¹, Zhi Geng^{2

3}, Andrew E Epstein^{1

4}, Saman Nazarian¹, Rajat Deo¹, Francis E Marchlinski¹, Peter W Groeneveld^{2

3

4}, David S Frankel¹

Affiliations

¹ Cardiovascular Division (T.M.M., A.E.E., S.N., R.D., F.E.M., D.S.F.), Perelman School of Medicine.
² Division of General Internal Medicine (Z.G., P.W.G.), Perelman School of Medicine.
³ Center for Cardiovascular Outcomes, Quality, and Evaluative Research (Z.G., P.W.G.), University of Pennsylvania, Philadelphia.
⁴ Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA (A.E.E., P.W.G.).

Timothy M Markman et al. Circulation. 2020.

. 2020 Mar 17;141(11):937-939.

doi: 10.1161/CIRCULATIONAHA.119.044109. Epub 2020 Mar 16.

Timothy M Markman¹, Zhi Geng^{2

3}, Andrew E Epstein^{1

4}, Saman Nazarian¹, Rajat Deo¹, Francis E Marchlinski¹, Peter W Groeneveld^{2

3

4}, David S Frankel¹

¹ Cardiovascular Division (T.M.M., A.E.E., S.N., R.D., F.E.M., D.S.F.), Perelman School of Medicine.
² Division of General Internal Medicine (Z.G., P.W.G.), Perelman School of Medicine.
³ Center for Cardiovascular Outcomes, Quality, and Evaluative Research (Z.G., P.W.G.), University of Pennsylvania, Philadelphia.
⁴ Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA (A.E.E., P.W.G.).

No abstract available

Keywords: antiarrhythmic drugs; arrhythmias; atrial fibrillation; supraventricular tachycardia; ventricular tachycardia.

Publication types